- £1.50bn
- -£8.46bn
- £745.50m
- 86
- 69
- 86
- 95
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 697 | 761 | 756 | 795 | 746 |
Cost of Revenue | |||||
Gross Profit | 557 | 607 | 621 | 664 | 627 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 518 | 563 | 552 | 528 | 539 |
Operating Profit | 178 | 199 | 204 | 267 | 207 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 178 | 199 | 204 | 267 | 213 |
Provision for Income Taxes | |||||
Net Income After Taxes | 140 | 156 | 155 | 205 | 164 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 140 | 155 | 154 | 205 | 164 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 140 | 155 | 154 | 205 | 164 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.152 | 0.167 | 0.173 | 0.211 | 0.181 |
Dividends per Share |